PharmaCielo Ltd. (PCLOF) Financials

PCLOF Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 6.2 million 17.4 million
Sept. 30, 2025 6.2 million 16.9 million
June 30, 2025 13.3 million 21.4 million
March 31, 2025 12.8 million 19.3 million

PCLOF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 386814 19782
Sept. 30, 2025 -2.5 million 19478
June 30, 2025 1.6 million ?
March 31, 2025 -66238 ?

PCLOF Net Income

No data available :(

PCLOF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 210801 - -
Sept. 30, 2025 184261 - -
June 30, 2025 4810 - -
March 31, 2025 37288 3.2 million -

PCLOF Shares Outstanding

No data available :(

PCLOF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 3 - 234326 323
Sept. 30, 2025 2 - 1.5 million 3152
June 30, 2025 - - 611457 -
March 31, 2025 2 - 881008 -

PCLOF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 441764 -287217
Sept. 30, 2025 638479 995200
June 30, 2025 237221 227810
March 31, 2025 546727 464898

PCLOF

Price: $0.04

52 week price:
0.00
0.12

Earnings Per Share: -0.04 USD

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 8.6 million

Links: